Abbott Laboratories (ABT) - Get Report said Wednesday that its fourth-quarter sales benefited from a surge of nearly 30% for its Covid-19 rapid testing platforms.
Shares of the North Chicago, Ill. company were rising in premarket trading to $115.30.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,